Skip to main content
. 2009 Oct 20;4(10):e7517. doi: 10.1371/journal.pone.0007517

Table 1. Peptides used for the plaque-reduction assay.

Peptide name Peptide sequence
PB11–25A-Tat MDVNPTLLFLKVPAQNAISTTFPYTYGRKKRRQRRRPP
PB11–25AT6Y-Tat MDVNPYLLFLKVPAQNAISTTFPYTYGRKKRRQRRRPP
PX-Tat LSNDELIKKLVTELAENSMIEAEEVYGRKKRRQRRRPP

The underlined Y highlights the tyrosine residue derived from the PB1 FluB sequence. Bold letters in italics represent the HIV-Tat derived sequence that allow the peptides to cross the plasma membrane.